文献

J-GLOBAL ID：201302241668348060   整理番号：13A0011779

心房細動の日本人患者におけるリバロキサバンとワルファリンの比較-J-ROCKET AF研究-

Rivaroxaban vs. Warfarin in Japanese Patients With Atrial Fibrillation - The J-ROCKET AF Study -

著者 (13件)： HORI Masatsugu (Osaka Medical Center for Cancer and Cardiovascular Diseases) ,  MATSUMOTO Masayasu (Dep. of Clinical Neuroscience and Therapeutics, Hiroshima Univ.) ,  TANAHASHI Norio (Dep. of Neurology, Saitama Medical Univ. International Medical Center) ,  MOMOMURA Shin-ichi (Div. of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical Univ.) ,  UCHIYAMA Shinichiro (Dep. of Neurology, Tokyo Women’s Medical Univ.) ,  GOTO Shinya (Dep. of Medicine (Cardiology), Tokai Univ. School of Medicine) ,  IZUMI Tohru (Dep. of Cardio-angiology, Kitasato Univ. School of Medicine) ,  KORETSUNE Yukihiro (Inst. for Clinical Res., Osaka National Hospital) ,  KAJIKAWA Mariko (Bayer Yakuhin Ltd) ,  KATO Masaharu (Bayer Yakuhin Ltd) ,  UEDA Hitoshi (Bayer Yakuhin Ltd) ,  IWAMOTO Kazuya (Bayer Yakuhin Ltd) ,  TAJIRI Masahiro (Bayer Yakuhin Ltd)
資料名： Circulation Journal  (Circulation Journal)
巻： 76  号： 9  ページ： 2104-2111 (J-STAGE)  発行年： 2012年 
JST資料番号： F0908A  ISSN： 1346-9843  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： 日本 (JPN)  言語： 英語 (EN)

抄録/ポイント： 背景:国際的ROCKET AF試験では,心房細動(AF)患者...

シソーラス用語： ヒト ,...
準シソーラス用語： J-ROCKET AF ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=13A0011779&from=J-GLOBAL&jstjournalNo=F0908A") }}

分類 (1件)： 血液・体液作用薬の臨床への応用  (GW14020X)

物質索引 (2件)： リバロキサバン ,  ワルファリン

引用文献 (13件)：

•  1. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 2008; 133: 160S–198S.
•  2. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114: 700–752.
•  3. Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011; 365: 883–891.
•  4. Japanese Circulation Society Joint Working Group. Guidelines for pharmacotherapy of atrial fibrillation (JCS 2008): Digest version. Circ J 2010; 74: 2479–2500.
•  5. Atarashi H, Inoue H, Okumura K, Yamashita T, Kumagai N, Origasa H. Present status of anticoagulation treatment in Japanese patients with atrial fibrillation. Circ J 2011; 75: 1328–1333.

タイトルに関連する用語 (7件)： 心房細動 ,  日本人 ,  患者 ,  リバロキサバン ,  ワルファリン ,  AF ,  研究